BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2010
View Archived Issues
MedImmune reports clinical data on asthma candidates MEDI-563 and MEDI-528
Read More
PH-797804 improves lung function in patients with COPD
Read More
Preclinical and clinical data reported on neoglycoside ACHN-490
Read More
Intranasal XF-73 well tolerated in phase I study
Read More
Phase I data support safety of TissueGene-C in osteoarthritis
Read More
Plexxikon discloses new inhibitors of protein kinases
Read More
Maximum tolerated dose of ARRY-380 established in patients with breast cancer
Read More
Achillion begins dosing in phase IIa trial of ACH-1625 in HCV infection
Read More
Global marketing rights to Caelyx to transition from Merck & Co. to Janssen
Read More
Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents
Read More
Barcelona researchers claim new apoptosis inducers
Read More
Trophos begins clinical development of TRO-40303
Read More
Embera NeuroTherapeutics obtains NIDA grant for EMB-001 development
Read More
Pierre Fabre Medicament discloses new 11-beta-HSD1 inhibitors
Read More
Argenta and Janssen enter into cancer drug discovery agreement
Read More
Cortex Pharma regains rights to Ampakine agents for depression and schizophrenia
Read More
Merck Serono discovers new lysophospholipid S1P1 receptor antagonists
Read More
Cellceutix completes toxicity studies of anticancer agent Kevetrin
Read More
SEPS Pharma presents new antifungal agents
Read More
CHMP recommends variation to terms of marketing authorization for Invega
Read More
AcelRx completes end-of-phase II meeting with FDA on ARX-02 Sufentanil NanoTab
Read More
GSK discontinues Simplirix development for genital herpes
Read More
Biomarker analysis demonstrates potential of MGN-1703 against cancer
Read More
PEGASUS-TIMI 54 trial to evaluate long-term post-ACS efficacy and safety of ticagrelor
Read More
GW Pharma begins phase IIa trial of cannabinoids in type 2 diabetes
Read More
FDA requests change in tapentadol ER formulation in complete response letter to J&JPRD
Read More